Chronic Bronchiolitis or Resistant Asthma?

Chronic Bronchiolitis or Resistant Asthma? Testing a way to diagnosis and...

Date First Received: August 22, 2006

Last Updated: November 29, 2006

Verified by: Baqiyatallah Medical Sciences University, January 2006

Clinical Trial Phase: Phase 4 | Start Date: 

Overall Status: Completed

Brief Summary

Condition Keyword(s):

Chronic Bronchiolitis or Resistant Asthma? Testing a way to diagnosis and treatment

Study Type: Interventional

Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment

Intervention(s) in this Clinical Trial

  • Drug: Erythromycin, Azithromycin , Clarithromycin

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Difficult asthma

Exclusion Criteria:

  • Patients with potential allergic bronchopulmonary aspergillosis i.e. with peripheral blood eosinophilia, sputum eosinophilia, or any sputum production and bronchiectasis
  • A history of smoking
  • Significant occupational or environmental exposures
  • Evidence on emphysema on chest high resolution computed tomography (HRCT) scan

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: N/A

Maximum Age for this Clinical Trial: N/A

Clinical Trial Sponsor Information

Lead Sponsor: Baqiyatallah Medical Sciences University

Overall Clinical Trial Officials and Contacts

Mostafa Ghanei, Prof Principal Investigator Research Center of Chemical Injuries, Baqyatallah Medical Sciences University, Tehran, Iran  

Additional Information

Information obtained from ClinicalTrials.gov on October 07, 2008

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00368342

Study ID Number: S-340-14-6-1-PU-79

ClinicalTrials.gov Identifier: NCT00368342

Health Authority: Iran: Ethics Committee

Clinical Trials Authorship and Review

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.